Judith Flores, Ronen Arnon, Raffaella A. Morotti, Lisa Guay‐Woodford, Sukru Emre, Benjamin L. Shneider – 23 April 2008 – A 9‐year‐old male underwent deceased donor liver transplantation for idiopathic fulminant hepatic failure. In the postoperative period, a review of perioperative biopsies of the donor liver revealed mild features of congenital hepatic fibrosis. Over the ensuing year, the recipient developed severe complications of congenital hepatic fibrosis including multiple episodes of cholangitis and progressive portal hypertension.

Dorico Righi, Alessandro Franchello, Alessandro Ricchiuti, Andrea Doriguzzi Breatta, Karine Versace, Amedeo Calvo, Renato Romagnoli, P. Fonio, Giovanni Gandini, Mauro Salizzoni – 23 April 2008 – Biliary leaks complicating hepaticojejunostomy (HJA) or fistulas from cut surface are severe complications after liver transplantation (LT) and split‐liver transplantation (SLT). The aim of the study was to describe our experience about the safety and efficacy of radiological percutaneous treatment without dilatation of intrahepatic biliary ducts.

Cataldo Doria, Elia S. Elia, Yoogoo Kang, Albert Adam, Anik Desormeaux, Carlo Ramirez, Adam Frank, Fabrizio di Francesco, Jay H. Herman – 23 April 2008 – Acute hypotensive transfusion reactions are newly characterized transfusion reactions in which hypotension is the prominent feature. The pathophysiology of acute hypotensive transfusion reactions is related to the bradykinin function and its metabolism.

Estella M. Alonso – 23 April 2008

Shimon Kusne, Manjushree Gautam – 23 April 2008

Derek DuBay, Rob J. Smith, Kenneth G. Qiu, Gary A. Levy, Leslie Lilly, George Therapondos – 23 April 2008 – The purpose of this study is to review the clinical experience with sirolimus immunosuppression in liver transplant patients with calcineurin inhibitor–induced chronic renal insufficiency. The study design is a case‐control retrospective series. Fifty‐seven liver transplant patients with renal insufficiency that were started on sirolimus at greater than 90 days postoperatively and treated for more than 90 days were identified.

James D. Perkins – 23 April 2008

Kristin L. Mekeel, Adyr A. Moss, Kunam S. Reddy, David D. Douglas, Hugo E. Vargas, Elizabeth J. Carey, Thomas J. Byrne, M. E. Harrison, Jorge Rakela, David C. Mulligan – 23 April 2008 – In the current Model for End‐Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved.

Ranjeeta Bahirwani, Mical S. Campbell, Tim Siropaides, James Markmann, Kim Olthoff, Abraham Shaked, Roy D. Bloom, K. Rajender Reddy – 23 April 2008 – Pre–liver transplant renal dysfunction is associated with decreased survival following transplantation and is also a prognostic indicator of posttransplant chronic kidney disease.

Matteo Cescon, Gian Luca Grazi, Alessandro Cucchetti, Matteo Ravaioli, Giorgio Ercolani, Marco Vivarelli, Antonietta D'Errico, Massimo Del Gaudio, Antonio Daniele Pinna – 23 April 2008 – Advanced donor age is a risk factor for poor outcome in liver transplantation (LT). We reviewed 553 consecutive transplants according to donor age categories [group 1 (n = 173): <50 years; group 2 (n = 96): 50–59 years; group 3 (n = 132): 60–69 years; group 4 (n = 111): 70–79 years; group 5 (n = 41): ≥80 years]. Clinical parameters were comparable between groups.